Zoetis | ZTS - Les Charges D'Exploitation

Prix De L'Action
116.87
Variation Quotidienne
0.81 0.70%
Mensuellement
0.14%
Annuel
-23.85%
Q2 Prévisions
114.37




Les Charges D'Exploitation Changement Date
AbbVie USD 10.81B 13.45B 2025-12
Align Technology USD 822.85M 11.8M 2025-12
Bayer EUR 10.33B 126M 2025-12
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Charles River Laboratories USD 918.41M 2.49B 2025-12
Coherus Biosciences USD 51.83M 2.48M 2025-12
Dentsply International USD 423M 1.06B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Henry Schein USD 3.25B 110M 2025-12
Idexx Laboratories USD 774.97M 24.58M 2025-12
Illumina USD 903M 69M 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
J&J USD 17.44B 1.53B 2026-03
Laboratory Of America USD 3.13B 32.4M 2025-12
Merck USD 10.16B 558M 2025-12
Neogen USD 214.5M 15.57M 2025-12
Pacira USD 193.68M 27.32M 2025-12
Perrigo USD 1.03B 75.3M 2025-12
Pfizer USD 12.91B 79.89B 2025-12
Phibro Animal Health USD 332.36M 20.68M 2025-12
Quest Diagnostics USD 2.5B 76M 2026-03
Sanofi EUR 9.31B 1.2B 2026-03
Sanofi EUR 10.71B 1.32B 2025-12
Zoetis USD 1.55B 3.85B 2025-12